welcome to summit

Summit is an Oxford, UK based drug discovery company with a portfolio of partner funded drug programmes and an innovative Seglin™ technology platform for the discovery of new medicines.

Our Partnerships
A proven commercial track record

Our partner funded programme portfolio has the potential to generate significant value.

Seglin Technology
Seglin

Our drug discovery engine for entering into new programme and technology deals.

Our Programmes
Our Programmes

Our early-stage programme pipeline targets major areas of high unmet medical need.

current share price:

LSE (SUMM): 4.62p +0.00p
at 11:34am   30 Jul 2010
15 minute delayed share price from London Stock Exchange provided by Hemscott Group Limited

latest news:

17th June 2010